Charles River Laboratories International (CRL) Faces Biotech R&D Spending Headwinds [Yahoo! Finance]
Charles River Laboratories International, Inc. (CRL) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
Charles River Laboratories to Present at TD Cowen and Barclays Conferences
Charles River Laboratories International (CRL) had its price target raised by UBS Group AG from $170.00 to $175.00. They now have a "neutral" rating on the stock.
IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities [Yahoo! Finance]